Skip to main content

The IND Program has launched the Early Clinical Trials Educational Series

The IND Program has launched the Early Clinical Trials Educational Series

The CCTG IND Program has launched the Early Clinical Trials Educational Series, a virtual education workshop series that offers topics of relevance and interest to early drug trial investigation. The series curriculum covers early clinical trial design and conduct, planning correlative analyses, data interpretation and publication of results, as well as operational considerations and policy and regulatory framework.

Who should attend

The Early Clinical Trials Educational Series is open to oncology fellows, residents, early career investigators, and other trainees at CCTG member institutions. Interested participants and fellows interested in volunteering to facilitate a future session can contact Laura Pearce, lpearce@ctg.queensu.ca

About the workshops

The workshops are delivered by leading Canadian and International experts. The first successful session of this series, Patient Perspectives/Engagement & Equity, was held January 30, 2026 and the upcoming workshops are: 

  1. Session #2: Interactive Workshop on Design and Execution of Phase I Trials | March 18, 12-1 pm
  2. Session #3: Phase II Oncology Studies: Do they still Exist? | June 5, 12-1 pm
  3. Session #4: Pre-clinical Data Interpretation and Guidelines | Sept 18, 12-1 pm
  4. Session #5: Design and Execution of Early Cell Therapy Trials: Special Considerations | Nov 6, 12-1 pm
  5. Session #6: Academic/Industry Drug Development: Crossing to the ‘dark side’ or a World of Opportunity? | Jan 15, 2027

 

More information about the speakers and dates can be found in the posters below.  

 

Design and Execution of Phase 1 trialsPhase II Oncology Studies: Do they still Exist?Preclinical Data Interpretation and Guidelinessession 5 - design and execution of ealy cell therapy trialsSession #6: Academic/Industry Drug Development: Crossing to the ‘dark side’ or a World of Opportunity?